CARDIAC RESEARCH

Paradise-MI

This is a double blind randomized Phase 3 study to evaluate the efficacy and safety of Entresto compared to Ramipril in high risk patients following an acute MI. Patients are identified at time of hospital admission and then screened for eligibility.

aMAZE

This is a study to evaluate the effectiveness of the LARIAT system to isolate and ligate the LAA from the left atrium as an adjunct to planned PVI catheter ablation in the treatment of subjects with symptomatic persistent atrial fibrillation. Patients are randomized 2:1 to Lariat and PVI verses just PVI alone.

PREEMPT-HF

This is a study to investigate the association between heart failure sensor data and 30-day heart failure hospital readmissions using the HeartLogic Heart Failure Diagnostic in heart failure patients with a Boston Scientific ICD (implantable cardioverter defibrillator). This study has not started enrollment yet.

Prominent

This study that will test the hypothesis that pemafibrate will reduce rates of myocardial infarction, ischemic stroke, unstable angina requiring unplanned revascularization, and cardiac death in patients with type 2 diabetes who have elevated triglycerides, low HDL, on statin therapy and at a high risk for future cardiovascular events. This study has not started enrollment yet.

Navigate X 4

This is a study to collect information about the safety and performance of the Boston Scientific ACUITY X 4 Quadripolar Coronary Venous Leads and RELIANCE 4-Front Ventricular Defibrillation Leads. This study is closed to enrollment, both leads are now FDA approved, and follow up device checks continue.

Cobra PzF Shield

The purpose of this study is to collect information about the safety and effectiveness of the COBRA PzF Coronary Stent System in the treatment of new lesions in coronary arteries. The study is closed to enrollment but follow up continues.

“The ENTIRE staff at the Grants Pass office is WONDERFUL! They always treat us with friendly and professional service.”

Grants Pass Patient